BIO

Bio-Rad Laboratories, Inc.

Technology
306.13 +0.67 +0.22% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 8.25B
EV —
Shares Out 26.96M
Revenue (ttm) 2.59B
Net Income 168.80M
Beta —
P/E -35.36
Forward P/E —
EPS (ttm) $6.01
P/S —
P/B 1.20
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 1.72%
ROE 2.5%
ROIC —
Gross Margin 51.87%
Oper. Margin 2.22%
Profit Margin 6.52%
Debt/Eq 0.14
LT Debt/Eq 10.49%
Quick Ratio —
Current Ratio 3.21
Book/sh 254.15
Cash/sh 18.81
Div Yield —
Div TTM —
Payout Ratio —
SMA20 10.91%
SMA50 9.67%
SMA200 4.24%
Volume 405,400
Avg Volume 348.09K
Rel Volume —
Perf Week -2.03%
Perf Month 19.06%
Perf Quarter 9.71%
Perf Half Y -3.64%
Perf YTD 1.04%
Perf Year 39.59%
Perf 3Y -16.95%
Perf 5Y -47.34%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems, reagents, and consumables. The company operates in two industry segments: Life Science and Clinical Diagnostics. The Life Science segment develops instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials including cells, proteins, and nucleic acids for research, biopharmaceutical laboratory environments, biopharmaceutical manufacturing, quality control processes, food safety testing, and science education applications. The Clinical Diagnostics segment designs and manufactures diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories, offering more than 300 in vitro diagnostic tests. Bio-Rad has direct operations in over 36 countries, with approximately 40% of revenues from the U.S. and 60% from international locations, with Europe being the largest international region. The company estimates worldwide sales in Life Science markets to be approximately $19 billion and in Clinical Diagnostics markets to be approximately $16 billion.

Name
Bio-Rad Laboratories, Inc.
Industry
Technology
CEO
Norman Schwartz · Chief Executive Officer and Chairman of the Board
Employees
7,450 as of 2025-12-31
IPO Date
2011-06-15
Phone
(510) 724-7000
Address
1000 Alfred Nobel Drive, Hercules, CA 94547
Website
www.bio-rad.com

Key Executives

Name Title FY Pay
Arnold A. Pinkston Director —
Melinda Litherland Director —
Gregory K. Hinckley Director —
Jeffrey L. Edwards Director —
Norman Schwartz Chief Executive Officer and Chairman of the Board —

Latest News